Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/33965
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorMesa Arango, Ana Cecilia-
dc.contributor.authorScorzoni, Liliana-
dc.contributor.authorZaragoza Hernández, Oscar-
dc.date.accessioned2023-03-13T20:07:47Z-
dc.date.available2023-03-13T20:07:47Z-
dc.date.issued2012-
dc.identifier.urihttps://hdl.handle.net/10495/33965-
dc.description.abstractABSTRACT “Amphotericin B acts through pore formation at the cell membrane after binding to ergosterol” is an accepted dogma about the action mechanism of this antifungal, and this sentence is widely found in the literature. But after 60 years of investigation, the action mechanism of Amphotericin B is not fully elucidated. Amphotericin B is a polyene substance that is one of the most effective drugs for the treatment of fungal and parasite infections. As stated above, the first mechanism of action described was pore formation after binding to the ergosterol present in the membrane. But it has also been demonstrated that AmB induces oxidative damage in the cells. Moreover, amphotericin B modulates the immune system, and this activity has been related to the protective effect of the molecule, but also to its toxicity in the host. This review tries to provide a general overview of the main aspects of this molecule, and highlight the multiple effects that this molecule has on both the fungal and host cells.spa
dc.format.extent10spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherFrontiers Research Foundationspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleIt only takes one to do many jobs : Amphotericin B as antifungal and immunomodulatory drugspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGRID - Grupo de Investigación Dermatológicaspa
dc.identifier.doi10.3389/fmicb.2012.00286-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1664-302X-
oaire.citationtitleFrontiers in Microbiologyspa
oaire.citationstartpage1spa
oaire.citationendpage10spa
oaire.citationvolume3spa
oaire.citationissue286spa
thesis.degree.disciplinesin facultad - programaspa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
dc.publisher.placeLausana, Suizaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTREVspa
dc.type.localArtículo de revisiónspa
dc.subject.decsAmphotericin B-
dc.subject.decsAnfotericina B-
dc.subject.decsImmunomodulation-
dc.subject.decsInmunomodulación-
dc.subject.decsMycoses-
dc.subject.decsMicosis-
dc.subject.decsMitochondrial Permeability Transition Pore-
dc.subject.decsPoro de Transición de la Permeabilidad Mitocondrial-
dc.subject.decsOxidative Stress-
dc.subject.decsEstrés Oxidativo-
dc.identifier.urlhttps://www.frontiersin.org/articles/10.3389/fmicb.2012.00286/fullspa
dc.description.researchgroupidCOL0050839spa
dc.relation.ispartofjournalabbrevFront. Microbiol.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
MesaAna_2012_ AmphotericinBAntifungalImmunomodulatory.pdfArtículo de revisión692.12 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons